Rectal Cancer

Who we are

  • April 5, 2022
    Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients
  • April 5, 2022
    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
  • April 5, 2022
    Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
  • April 5, 2022
    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients